Open Label Extension to Assess the Safety of Long-Term Treatment With Ampion for Severe Osteoarthritis (OA) of the Knee

Summary

This Open Label Extension (OLE) study will assess the safety of long-term treatment with a 4 mL intra-articular injection of Ampion™ in adults with pain due to severe osteoarthritis of the knee

Timeline

Start

2017-12-08

Primary completion

2018-10-04

Completion

2018-10-04

Outcome

Outcome not reported

Stopped: “Study terminated by Sponsor due to absence of significant safety findings.”

Drugs

Indications